{"prompt": "['Trial ID: LP0133-1273', 'Date: 07-Dec-2018', 'Version: 3.0', 'Page 3 of 128', 'Protocol amendment summary of changes table', 'Document history', 'Document', 'Protocol version', 'Date', 'Type of protocol amendment', 'Amendment 2', '3.0', '07-Dec-2018', 'Global', '(substantial)', 'Amendment 1', '2.0', '11-Jul-2018', 'Global', '(substantial)', 'Original protocol', '1.0', '08-May-2018', 'Not applicable', 'Note that the protocol amendment summary of changes table for the previous amendment is', 'provided in Appendix 6.', 'Amendment 2 (07-Dec-2018)', 'This amendment is considered to be substantial based on the criteria set forth in Article 10(a)', 'of Directive 2001/20/EC of the European Parliament and the Council of the European Union', 'or subsequent regulation.', 'Overall rationale for the amendment', 'The main reason for the amendment is to address comments to the protocol received from the', 'U.S. Food and Drug Administration. Miscellaneous other changes/updates have also been', 'implemented.', 'The table below presents changes made in each section and a brief rationale for each change.', 'Changes have been either summarised (written with plain text only) or marked as tracked', 'changed (new text that has been added to the protocol is highlighted in bold and text that has', 'been removed from the protocol is highlighted with a line through the text).']['Trial ID: LP0133-1273', 'Date: 07-Dec-2018', 'Version: 3.0', 'Page 4 of 128', 'Section no. and', 'Description of change', 'Brief rationale', 'name', 'Section 1', 'Change of treatment success abbreviation', 'To reflect changes in the', 'Protocol', 'from IGA 0/1 to IGA TS.', 'protocol.', 'synopsis', 'Patient Global Impression of Change (PGI-', 'C) has been added to the list of subject', 'assessments of efficacy and health-related', 'quality of life; PROs.', 'Subject assessment of local tolerability has', 'been added as a safety assessment.', 'Exclusion criterion slightly revised:', '\"Concurrent skin diseases on the hands, e.g.', 'tinea manuum\".', 'Exclusion criterion revised: \"Tuberculosis', 'requiring treatment within 12 months prior', 'to screening and/or subjects with a', 'positive blood test for tuberculosis at', 'screening*.', '* Subjects with high risk of latent', 'tuberculosis (e.g. prior residence in or', 'travel to countries with high prevalence of', 'tuberculosis, close contact with a person', 'with active tuberculosis, or a history of', 'active or latent tuberculosis where an', 'adequate course of treatment cannot be', 'confirmed) must be tested.\"', 'Section 4', 'Assessment of PGI-C added.', 'Added as a PRO anchor', 'Schedule of trial', 'scale to generate a', 'procedures', 'threshold for', 'improvement that', 'represents a meaningful', 'amount of change in the']['Trial ID: LP0133-1273', 'Date: 07-Dec-2018', 'Version: 3.0', 'Page 5 of 128', 'target population.', 'Tuberculosis test added.', 'To reflect that subjects', 'with high risk of latent', 'tuberculosis (e.g. prior', 'residence in or travel to', 'countries with high', 'prevalence of', 'tuberculosis, close', 'contact with a person', 'with active tuberculosis,', 'or a history of active or', 'latent tuberculosis where', 'an adequate course of', 'treatment cannot be', 'confirmed) must be', 'tested.', 'Subject assessment of local tolerability', 'Added to have an active', 'added.', 'subject assessment of', 'local tolerability in the', 'trial.', 'Assessment of new chronic hand eczema', 'To reflect that the', 'lesions added.', 'investigator will check', 'for new chronic hand', 'eczema lesions at the', 'visits indicated in the', 'schedule of trial', 'procedures.', 'Change to footnote on medical history:', 'To clarify that it is not', '\"Relevant medical history must be recorded', 'the intention that full', \"from the subject's date of birth. In case\", 'medical history is to be', 'medical history is incomplete at screening', 'recorded both at', 'visit, missing data will be retrieved at Day', 'screening and at baseline.', '1 (baseline).']\n\n###\n\n", "completion": "END"}